European Archives - Page 71 of 1370 - European Medical Journal

Texting Programs Show Real Gains in Diabetes Control - EMJ

Simple Text Messages Boost Diabetes Control

A new meta-analysis finds that simple, low-cost text message interventions can improve short-term blood sugar control in adults with diabetes.

Revised Milk OIT Reduces Severe Gastrointestinal Reactions

Revised Milk Allergy Therapy Reduces Severe Gastrointestinal Reactions

A new milk allergy therapy protocol lowers the severity of gastrointestinal reactions during OIT, improving safety for patients.

26 Nov 2025

Recent Developments in Chronic Lymphocytic Leukaemia Research: Interview with an Expert

Explore the latest advancements in chronic lymphocytic leukaemia research and treatment with Talha Munir…

Doctor and patient discussing depression

AbbVie and BioMed X to study science of lost joy

The two companies have launched a collaborative research initiative to investigate anhedonia in depression, hoping to solve huge unmet needs.

PCSK9

PCSK9 Emerges as Early Marker of Autoimmune Liver Disease

A new study suggests that the cholesterol-regulating protein PCSK9 may serve as a sensitive early biomarker for autoimmune liver diseases, helping identify patients even when routine liver tests appear normal.

25 Nov 2025

Why Are You Still Avoiding PD in Patients with Obesity?

In this interactive case study, explore how to approach dialysis modality selection for patients living with obesity, and why peritoneal…

smoking

Even Low Levels of Smoking Linked to Heart Disease

New research reveals that low intensity smoking still drives major cardiovascular risks. Find out what the data shows.

BMI

BMI Not Linked to Distal Interphalangeal Joint Osteoarthritis in Rheumatoid Arthritis

Study finds body mass index does not affect incidence or progression of distal interphalangeal joint osteoarthritis in rheumatoid arthritis patients.

Menopause

Women Largely Uninformed About Menopause

Most women lack essential knowledge about menopause, a new UCL study finds.

Sorfequiline Shows Promise in Shortened Tuberculosis Therapy

Sorfequiline, combined with pretomanid and linezolid, shows superior efficacy and safety in drug-sensitive TB, supporting its potential role in ultra-short treatment regimens.